Very interesting territory for this companies earnings.
They haven't sold anything new but have been getting gov't funding and donors.
GILD gave away their supply of treatment.

Personally I think earnings will be bad but will still rise into it.
Beyond Technical AnalysisTrend AnalysisTrend Lines

Exención de responsabilidad